These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1753 related articles for article (PubMed ID: 23506232)

  • 41. Prevalence of attention-deficit/hyperactivity disorder and conduct disorder among substance abusers.
    Schubiner H; Tzelepis A; Milberger S; Lockhart N; Kruger M; Kelley BJ; Schoener EP
    J Clin Psychiatry; 2000 Apr; 61(4):244-51. PubMed ID: 10830144
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Familial risk analysis of the association between attention-deficit/hyperactivity disorder and psychoactive substance use disorder in female adolescents: a controlled study.
    Biederman J; Petty CR; Monuteaux MC; Mick E; Clarke A; Ten Haagen K; Faraone SV
    J Child Psychol Psychiatry; 2009 Mar; 50(3):352-8. PubMed ID: 19309331
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Prospective study of adolescent drug use among community samples of ADHD and non-ADHD participants.
    August GJ; Winters KC; Realmuto GM; Fahnhorst T; Botzet A; Lee S
    J Am Acad Child Adolesc Psychiatry; 2006 Jul; 45(7):824-32. PubMed ID: 16832319
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Teacher reports of DSM-IV ADHD, ODD, and CD symptoms in schoolchildren.
    Nolan EE; Gadow KD; Sprafkin J
    J Am Acad Child Adolesc Psychiatry; 2001 Feb; 40(2):241-9. PubMed ID: 11211374
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Family functioning and psychosocial characteristics in children with attention deficit hyperactivity disorder with comorbid oppositional defiant disorder or conduct disorder].
    Kiliç BG; Sener S
    Turk Psikiyatri Derg; 2005; 16(1):21-8. PubMed ID: 15793695
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Familial clustering of symptoms and disruptive behaviors in multiplex families with attention-deficit/hyperactivity disorder.
    Smalley SL; McGough JJ; Del'Homme M; NewDelman J; Gordon E; Kim T; Liu A; McCracken JT
    J Am Acad Child Adolesc Psychiatry; 2000 Sep; 39(9):1135-43. PubMed ID: 10986810
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Dopamine and serotonin genetic risk scores predicting substance and nicotine use in attention deficit/hyperactivity disorder.
    Groenman AP; Greven CU; van Donkelaar MM; Schellekens A; van Hulzen KJ; Rommelse N; Hartman CA; Hoekstra PJ; Luman M; Franke B; Faraone SV; Oosterlaan J; Buitelaar JK
    Addict Biol; 2016 Jul; 21(4):915-23. PubMed ID: 25752199
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Psychiatric comorbidities in adolescents with attention-deficit hyperactivity disorder and their siblings.
    Yang LK; Shang CY; Gau SS
    Can J Psychiatry; 2011 May; 56(5):281-92. PubMed ID: 21586194
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Attention deficit hyperactivity disorder (ADHD) is associated with early onset substance use disorders.
    Wilens TE; Biederman J; Mick E; Faraone SV; Spencer T
    J Nerv Ment Dis; 1997 Aug; 185(8):475-82. PubMed ID: 9284860
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Significance of childhood conduct problems to later development of conduct disorder among children with ADHD: a prospective follow-up study.
    Mannuzza S; Klein RG; Abikoff H; Moulton JL
    J Abnorm Child Psychol; 2004 Oct; 32(5):565-73. PubMed ID: 15500034
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Comorbidity of attention-deficit/hyperactivity disorder with psychiatric disorder: an overview.
    Pliszka SR
    J Clin Psychiatry; 1998; 59 Suppl 7():50-8. PubMed ID: 9680053
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Role of conduct problems in the relation between Attention-Deficit Hyperactivity disorder, substance use, and gaming.
    Schoenmacker GH; Groenman AP; Sokolova E; Oosterlaan J; Rommelse N; Roeyers H; Oades RD; Faraone SV; Franke B; Heskes T; Arias Vasquez A; Claassen T; Buitelaar JK
    Eur Neuropsychopharmacol; 2020 Jan; 30():102-113. PubMed ID: 30292416
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Psychiatric comorbidity in adult attention deficit hyperactivity disorder: findings from multiplex families.
    McGough JJ; Smalley SL; McCracken JT; Yang M; Del'Homme M; Lynn DE; Loo S
    Am J Psychiatry; 2005 Sep; 162(9):1621-7. PubMed ID: 16135620
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Childhood attention-deficit/hyperactivity disorder and future substance use disorders: comparative meta-analyses.
    Charach A; Yeung E; Climans T; Lillie E
    J Am Acad Child Adolesc Psychiatry; 2011 Jan; 50(1):9-21. PubMed ID: 21156266
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Familial risk analysis of the association between attention-deficit/hyperactivity disorder and psychoactive substance use disorders.
    Milberger S; Faraone SV; Biederman J; Chu MP; Wilens T
    Arch Pediatr Adolesc Med; 1998 Oct; 152(10):945-51. PubMed ID: 9790603
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Behavioral symptoms of child mental disorders and lifetime substance use in adolescence: A within-family comparison of US siblings.
    Kim S; Kim D
    Drug Alcohol Depend; 2021 Feb; 219():108490. PubMed ID: 33385692
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Externalizing disorders and substance use: empirically derived subtypes in a population-based sample of adults.
    Rodgers S; Müller M; Rössler W; Castelao E; Preisig M; Ajdacic-Gross V
    Soc Psychiatry Psychiatr Epidemiol; 2015 Jan; 50(1):7-17. PubMed ID: 24907047
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Health-related quality of life in children and adolescents who have a diagnosis of attention-deficit/hyperactivity disorder.
    Klassen AF; Miller A; Fine S
    Pediatrics; 2004 Nov; 114(5):e541-7. PubMed ID: 15520087
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Adolescent outcomes of childhood attention-deficit/hyperactivity disorder in a diverse community sample.
    Bussing R; Mason DM; Bell L; Porter P; Garvan C
    J Am Acad Child Adolesc Psychiatry; 2010 Jun; 49(6):595-605. PubMed ID: 20494269
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Atomoxetine treatment in children and adolescents with attention-deficit/hyperactivity disorder and comorbid oppositional defiant disorder.
    Newcorn JH; Spencer TJ; Biederman J; Milton DR; Michelson D
    J Am Acad Child Adolesc Psychiatry; 2005 Mar; 44(3):240-8. PubMed ID: 15725968
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 88.